Cardiac Toxicity After Treatment for Childhood Cancer
                                                
                            ×
                            Success! 
                        
                        
                            ×
                            Error! 
                        
                        
                            ×
                            Information ! 
                        
                                                        
                                                Rights Contact Login For More Details
- Wiley
More About This Title Cardiac Toxicity After Treatment for Childhood Cancer
- English
English
                                                            Prominent contributors present articles dealing with such topics as the pathology of radiation and anthracycline-related cardiac injury, pathophysiology of anthracycline cardiomyopathy, results of various strategies for screening survivors for the presence of treatment-related cardiomyopathy and methods under development that may reduce the risk of anthracycline-related cardiac injury.                                                        
                                                                                    - English
English
                                                            Partial table of contents:  
                                                                                    Perspectives Regarding Cardiac Complications of Cancer Therapy in Pediatric Patients (J. Bricker).
The Pathology of Anthracycline Cardiotoxicity in Children, Adolescents, and Adults (M. Billingham & M. Masek).
Radiation-Related Heart Disease: Risks After Treatment of Hodgkin's Disease During Childhood and Adolescence (S. Hancock & S. Donaldson).
Anthracycline-Related Cardiac Damage (L. Steinherz, et al.).
Cardiac Function Following Cardiotoxic Therapy During Childhood: Assessing the Damage (R. Jakacki, et al.).
The Use of the Corrected QT Interval (QTc) in Screening for Anthracycline-Related Cardiotoxicity (C. Schwartz, et al.).
The Use of Cardioprotectant Agents in Combination with Anthracycline Chemotherapy (S. Berg, et al.).
Index.
 
                                    
                                    